Table 4

Trial schedule

Study procedureScreeningBaselineFollow-up
17 weeks
Consent/assent (adolescent+/-parents)X16 week intervention period
Consent (parents)X
Characteristics of ABI (CRF)X
Current medication (adolescent)XX
BRIEF parent-ratingXX
Parents
 Demographics, past medical historyX
 SDQ parent-ratedXX
 PHQ-9XX
 GAD-7XX
 CBQXX
 EQ-5D-5LXX
 CSRIXX
 RCADS parent versionXX
Adolescents
 Consent/assent (participants+/-parents)X
 BRIEF-2XX
 RCADSXX
 SDQXX
 CHU-9DXX
 CBQXX
Both parent and adolescent
 Treatment adherenceX
 Treatment acceptability ratingX
 Study participation feedbackX
 Qualitative telephone interviews (all)X
  • ABI, acquired brain injury; CBQ, Conflict Behaviour Questionnaire; CHU-9D, Child Health Utility 9D; CRF, case report form; CSRI, Client Service Receipt Inventory; BRIEF-2, Behaviour Rating Inventory of Executive Function, Second Edition; EQ-5D-5L, EuroQol 5 Dimensions 5 Levels Questionnaire; GAD7, Generalised Anxiety Disorder 7-item; PHQ-9, Patient Health Questionnaire 9; RCADS, Revised Child Anxiety and Depression Scale; SDQ, Strengths and Difficulties Questionnaire.